Search results
Results from the WOW.Com Content Network
Financials as of September 30, 2023. [update] [1] Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]
Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen. Early life. Collis was born in South Africa and attended the University of Witwatersrand, where he earned a Bachelor of Commerce. Collis is Jewish. Career
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
File:AmerisourceBergen logo.svg. Size of this PNG preview of this SVG file: 800 × 218 pixels. Other resolutions: 320 × 87 pixels | 640 × 174 pixels | 1,024 × 279 pixels | 1,280 × 349 pixels | 2,560 × 698 pixels. Original file (SVG file, nominally 1,024 × 279 pixels, file size: 14 KB) This is a file from the Wikimedia Commons.
2007. Free Cash Flow. $1.5 billion. $859 million. $900 million. $380 million. $710 million. Source: S&P Capital IQ. Now we know how much cash AmerisourceBergen is really pulling in each year.
AmerisourceBergen's (ABC) fiscal fourth-quarter results are likely to be driven by its core Pharmaceutical Distribution business despite a competitive industry.
Let's see if AmerisourceBergen Corporation (ABC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
AmerisourceBergen (ABC) registers strong growth in the Pharmaceutical Distribution segment and the World Courier business in Q4. AmerisourceBergen (ABC) Beats on Q4 Earnings, Issues '19 View Skip ...